By Andrea Figueras Adidas upgraded its full-year guidance on the back of Yeezy inventory reductions and a better-than-expected underlying business, despite a...
Adidas upgraded its full-year guidance on the back of Yeezy inventory reductions and a better-than-expected underlying business, despite a decline in revenue and operating profit in the third quarter.
The underlying operating profit--excluding any one-offs related to Yeezy and the underway strategic review--is now estimated around 100 million euros , up from a prior guidance around break-even level, the company said.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Pfizer slumps after slashing full-year profit forecast on tumbling Covid salesPfizer said slumping demand for its Comirnaty covid vaccine and its Paxlovid antiviral treatment will mean sharply lower revenues for the full year.
Consulte Mais informação »
Pfizer cuts full-year outlook due to declining sales of Covid-19-related productsShares of Pfizer are falling before the opening bell as the company cut its full-year outlook, citing declining sales of its COVID-19-related products. Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion. Its prior forecast was for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.
Consulte Mais informação »
Pfizer cuts full-year outlook due to declining sales of Covid-19-related productsShares of Pfizer are falling before the opening bell as the company cut its full-year outlook, citing declining sales of its COVID-19-related products
Consulte Mais informação »
NetScout’s stock drops 20% after full-year outlook reducedWallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.
Consulte Mais informação »
Orla lifts full-year guidanceTSX- and NYSE-listed Orla Mining has increased its full-year guidance, after a better-than-expected performance from its Camino Rojo mine, in Mexico. The Camino Rojo oxide mine produced and sold 32 425 oz and 31 060 oz of gold, respectively, during the third quarter.
Consulte Mais informação »
J&J’s stock rallies after profit and sales rise above expectations, full-year outlook increasedTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
Consulte Mais informação »